Nasus Pharma Ltd. (NSRX) has a consensus analyst rating of Buy, based on 1 analyst covering the stock. Of those, 1 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for NSRX is $22.00, representing a +895.5% upside from the current price of $2.21. Price targets range from a low of $22.00 to a high of $22.00.
